News in Numbers
$17.9bn
The osteoporosis market is expected to reach a valuation of $17.9bn across the seven major markets by 2033, as per a GlobalData analysis.
$250m
Emergent BioSolutions has received contract modifications worth $250m from the US Department of Health and Human Services for the supply of four medical countermeasures including anthrax and smallpox vaccines.
77%
Alimera Sciences shares jumped 77% after being acquired by ANI Pharmaceuticals.
44%
As per the World Health Organization, 44% of 28,292 applications for patients seeking medical care outside the West Bank have been denied or remain pending, between October 2023 and May 2024.
$35
Boehringer Ingelheim and AstraZeneca have introduced a $35 monthly price cap on inhalers as of 1 June, 2024, with GSK to follow suit no later than 1 January, 2025.
